Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients.

about

ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.Antineoplastic drugs and their analysis: a state of the art review.Therapeutic drug monitoring and tyrosine kinase inhibitors.

P2860

Q37652283-25356404-B566-476F-B5BF-A3E5A3F33075 Q39339684-A8EAADDB-A8A9-484A-8FC9-31BB0401EC98 Q41846251-64A5A7F2-74A6-4C6D-8579-753B7CB8CC76

P2860

Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients.

Item

http://www.wikidata.org/entity/Q54578490

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@en

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@nl

type

Item

label

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@en

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@nl

prefLabel

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@en

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@nl

P1476

Capillary electrophoresis meth ...... nic myeloid leukemia patients.

@en

P2093

Aline F Ferreira

http://www.w3.org/2001/XMLSchema#string

Cristiane M de Gaitani

http://www.w3.org/2001/XMLSchema#string

Fabíola A de Castro

http://www.w3.org/2001/XMLSchema#string

Keyller B Borges

http://www.w3.org/2001/XMLSchema#string

Tatiana O Ajimura

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Identification of imatinib mesylate degradation products obtained under stress conditions.

Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography.

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry.

Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.

Capillary electrophoresis as a versatile tool for the bioanalysis of drugs--a review.

Specific targeted therapy of chronic myelogenous leukemia with imatinib.

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Pharmacologic monitoring and determinants of intracytoplasmic drug levels.

P304

1885-1892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ELPS.201000642

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21710556

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients.

about

P2860

P2860

Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921